标题
Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 42, Pages 7495-7504
出版商
Baishideng Publishing Group Inc.
发表日期
2017-11-13
DOI
10.3748/wjg.v23.i42.7495
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits
- (2017) Ahad Eshraghian HEPATOLOGY
- Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis
- (2017) Yukiomi Nakade et al. HEPATOLOGY RESEARCH
- Inhibitory effects of vitamin E on osteocyte apoptosis and DNA oxidative damage in bone marrow hemopoietic cells at early stage of steroid-induced femoral head necrosis
- (2017) Yan-Bo Jia et al. Molecular Medicine Reports
- Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis
- (2017) Ahad Eshraghian et al. United European Gastroenterology Journal
- The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans
- (2016) Stefano Ballestri et al. ADVANCES IN THERAPY
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- The rise, the fall and the renaissance of vitamin E
- (2016) Angelo Azzi et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- Novel Pharmacotherapy Options for NASH
- (2016) Vlad Ratziu DIGESTIVE DISEASES AND SCIENCES
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation
- (2016) Jia-Hung Ye et al. Scientific Reports
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
- (2015) An Tang et al. DIABETES CARE
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
- (2015) Rohit Loomba et al. HEPATOLOGY
- Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease
- (2015) Sahar Mohamed El-Haggar et al. Hepatology International
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Nonalcoholic fatty liver disease and statins
- (2015) Konstantinos Tziomalos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification
- (2015) Carolin Lackner et al. SEMINARS IN LIVER DISEASE
- The Gut Microbiota and Nonalcoholic Fatty Liver Disease
- (2015) Howard Monsour et al. SEMINARS IN LIVER DISEASE
- Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
- (2015) Sanjaya Satapathy et al. SEMINARS IN LIVER DISEASE
- Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review
- (2015) Claudia P. Oliveira et al. Clinics and Research in Hepatology and Gastroenterology
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model
- (2014) Cindy Kunne et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Liraglutide Enhances Insulin Sensitivity by Activating AMP-Activated Protein Kinase in Male Wistar Rats
- (2014) Satoru Yamazaki et al. ENDOCRINOLOGY
- Pentoxifylline for the treatment of nonalcoholic fatty liver disease
- (2014) Tao Zeng et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Cardiovascular effects of statins, beyond lipid-lowering properties
- (2014) Christos G. Mihos et al. PHARMACOLOGICAL RESEARCH
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and thyroid dysfunction: A systematic review
- (2014) Ahad Eshraghian WORLD JOURNAL OF GASTROENTEROLOGY
- Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet
- (2013) Masateru Ushio et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
- (2013) Zun Xiang et al. BMC GASTROENTEROLOGY
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
- (2013) M. Ferwana et al. DIABETIC MEDICINE
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Maria Stepanova et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Rhabdomyolysis Developing Secondary to Atorvastatin Therapy in a Patient with Liver Cirrhosis
- (2013) Ahad Eshraghian et al. INTERNAL MEDICINE
- Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis
- (2013) Yusaku Shirai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells
- (2013) Eva Morán-Salvador et al. JOURNAL OF HEPATOLOGY
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
- (2013) Wei Wang et al. PLoS One
- Angiotensin II Facilitates Fibrogenic Effect of TGF-β1 through Enhancing the Down-Regulation of BAMBI Caused by LPS: A New Pro-Fibrotic Mechanism of Angiotensin II
- (2013) Yu-Sheng Li et al. PLoS One
- Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
- (2013) Yan-Yan Ma WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
- (2013) Takumi Hirata et al. International Journal of Endocrinology
- Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat
- (2012) Jeannie Chan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes
- (2012) Guifen Qiang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
- (2012) Thuy-Anh Le et al. HEPATOLOGY
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
- (2012) Claudia O. Zein et al. HEPATOLOGY
- Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
- (2011) Jamie E. Mells et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis
- (2011) J Massart et al. BRITISH JOURNAL OF PHARMACOLOGY
- Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
- (2011) Georgios S. Papaetis et al. CURRENT DRUG TARGETS
- Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
- (2011) Roberto Fogari et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
- (2010) Adeline Bertola et al. PLoS One
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
- (2008) C. Fernández-Miranda et al. DIGESTIVE AND LIVER DISEASE
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- The effect of thiazolidinediones on BMD and osteoporosis
- (2008) Allyson K McDonough et al. Nature clinical practice. Endocrinology & metabolism
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now